Search by company, product, service or certification
VisioCyt® Bladder allows an earlier diagnosis and monitoring of bladder cancer from a simple urine sample.
This innovative solution is based on a patented technology combining image analysis and artificial intelligence.
VisioCyt® Bladder, validated by a clinical multicentric prospective trial, is CE IVDR marked.
Keywords
About
VitaDX, a deep tech based in Rennes and Paris, develops and markets cancer diagnostic solutions combining artificial intelligence and image processing applied to cytology.
View company
